Overexpression of hepatocyte growth factor receptor in renal carcinoma cells indirectly stimulates tumor growth in vivo

被引:13
|
作者
Miyata, Y
Ashida, S
Nakamura, T
Mochizuki, Y
Koga, S
Kanetake, H
Shuin, T
Kanda, S
机构
[1] Nagasaki Univ, Grad Sch Med Sci, Dept Mol Microbiol & Immunol, Nagasaki 8528501, Japan
[2] Kochi Med Sch, Dept Urol, Kochi, Japan
[3] Nagasaki Univ, Dept Urol, Grad Sch Med Sci, Nagasaki 852, Japan
基金
日本学术振兴会;
关键词
hepatocyte growth factor; renal cell carcinoma; receptor tyrosine kinase; overexpression; PI-3; kinase; vascular endothelial growth factor; angiogenesis;
D O I
10.1016/S0006-291X(03)00281-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We examined the role of increased expression of HGFR kinase in in vivo growth of renal carcinoma. Human renal carcinoma cell line, ACHN cells, was transfected with plasmid encoding wild-type HGFR gene to generate cell lines with increased HGFR protein. ACHN cells with elevated HGFR expression, denoted clones 8 and 10, respectively, showed higher basal kinase activities of HGFR and PI3-kinase than those of empty-vector (mock)-transfected cells. Clone 8 and 10 cells grew similar to mock cells in culture. In mice, tumors of these clones grew more rapidly than those of mock cells. Microvessel density of clone 8 or 10 tumors was higher than that of mock tumors. Clone 8 and 10 cells secreted vascular endothelial growth factor-A (VEGF-A) more than mock cells and the secretion was PI3-kinase inhibitor, LY294002-sensitive. Anti-VEGF-A neutralizing antibody significantly inhibited tumor growth of clones 8 and 10 in mice. These results indicate for the first time that overexpression of HGFR tyrosine kinase in renal carcinoma cells participates in rapid tumor growth in vivo. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:892 / 897
页数:6
相关论文
共 50 条
  • [31] The emerging role of hepatocyte growth factor in renal diseases
    Mao, Song
    Zhang, Jianhua
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2016, 36 (03) : 303 - 309
  • [32] Hepatocyte growth factor in renal disease: cause or cure?
    Laping, NJ
    CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 56 (5-6) : 371 - 377
  • [33] Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma
    Minner, Sarah
    Rump, Dorothea
    Tennstedt, Pierre
    Simon, Ronald
    Burandt, Eike
    Terracciano, Luigi
    Moch, Holger
    Wilczak, Waldemar
    Bokemeyer, Carsten
    Fisch, Margit
    Sauter, Guido
    Eichelberg, Christian
    CANCER, 2012, 118 (05) : 1268 - 1275
  • [34] Increased hepatocyte growth factor and c-Met receptor expression in nasopharyngeal carcinoma
    Luan, Tian
    Yu, Yang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 7 (12): : 5583 - 5587
  • [35] Regulation of connective tissue growth factor (CTGF) by hepatocyte growth factor in human tubular epithelial cells
    Kroening, Sven
    Solomovitch, Svetlana
    Sachs, Martin
    Wullich, Bernd
    Goppelt-Struebe, Margarete
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (03) : 755 - 762
  • [36] Roles of hepatocyte growth factor and mast cells in thrombosis and angiogenesis
    Matsumori, A
    CARDIOVASCULAR DRUGS AND THERAPY, 2004, 18 (04) : 321 - 326
  • [37] Roles of Hepatocyte Growth Factor and Mast Cells in Thrombosis and Angiogenesis
    Akira Matsumori
    Cardiovascular Drugs and Therapy, 2004, 18 : 321 - 326
  • [38] Vascular endothelial growth factor expression is increased in renal cell carcinoma
    Nicol, D
    Hii, SI
    Walsh, M
    Teh, B
    Thompson, L
    Kennett, C
    Gotley, D
    JOURNAL OF UROLOGY, 1997, 157 (04) : 1482 - 1486
  • [39] Epithelial growth factor receptor (EGFR) pathway and renal cell carcinoma
    Alain Ravaud
    Henri de Clermont
    Gilles Pasticier
    Denis Smith
    Véronique Vendrely
    Jean Philippe Maire
    Targeted Oncology, 2007, 2 : 99 - 105
  • [40] Epithelial growth factor receptor (EGFR) pathway and renal cell carcinoma
    Ravaud, Alain
    de Clermont, Henri
    Pasticier, Gilles
    Smith, Denis
    Vendrely, Veronique
    Maire, Jean Philippe
    TARGETED ONCOLOGY, 2007, 2 (02) : 99 - 105